In the past decade, many tyrosine-kinase inhibitors have been introduced in oncology and haemato-oncology. Because this new class of drugs
ESMO European Society for Medical Oncology Oncology drugs cancer drugs cancers and drugs approved by the FDA that are not yet endorsed in
As the cost of oncology drugs increases, there has been a growing pressure to manage oncology drug spend, which some payers have done by
HCPCS/CPT Code. Drug Category. Medical Prior Auth. Required. Vantas. J9225. ONCOLOGY. NO. Vectibix. J9303. ONCOLOGY. YES. Velcade. J9041. ONCOLOGY. YES. Vidaza.
Keytruda, an immuno-oncology drug indicated for a variety of cancers, led oncology sales with $7.17 billionalmost doubling its 2024 revenue
Answers to questions about oncology drug shortages published herein are provided by the American Society of Clinical Oncology, Inc. (ASCO) for voluntary
drugs were in short supply in 2024, including 14 oncology drugs. The ongoing oncology drug shortage is increasingly affecting clinical
Oncology is the study of cancer. Oncology drug companies around the globe have been the hope and pride of millions of people.
We then limited the sample to anticancer drugs by excluding non-oncology drugs and oncology drugs indicated for diagnostic, supportive care or antiemetic
Comments